WHO WE ARE ?

We are a healthcare AI company focused on early detection and management of high burden diseases like chronic kidney disease through non-invasive digital biomarkers. Kidney diseases (CKD) only get detected when it’s too late to be treated and patients are left to life-long dialysis or transplant. WHO figures show dramatic rise of 32% of death due to CKD in last decade.

Diabetes, BP and lifestyle increase CKD

OUR INVESTOR :

RECOGNITION

International Society Of Nephrology

PAPER PUBLISHED

Early detection of CKD with digital biomarkers pilot study paper got accepted in ISN and presenting in ISN. Annual Congress 2020 in Abu Dhabi ISN is worlds largest Nephrologist society with 9000 members

UNAIDS

Selected at global digital health marketplace

To educate and address risk factors, of both acute and chronic kidney diseases through multilateral engagement and address many of the structural factors that affect kidney health like poverty, lack of education, malnutrition, disempowerment of women, poor sanitation, environmental exposures, and natural disasters in the context of 17 SDGs.